Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toke Bek

Showing results (161-170 of 225) with videos related to

Pageof 23
Sort By:
Diabetes Care|November 28, 2002
Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathySøren T Knudsen, Toke Bek, Per L Poulsen, et al.
American Journal of Hypertension|April 10, 2002
Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetesSøren Tang Knudsen, Per Løgstrup Poulsen, Klavs Würgler Hansen, et al.
Retina (Philadelphia, Pa.)|July 1, 2014
A nationwide study on the incidence of rhegmatogenous retinal detachment in Denmark, with emphasis on the risk of the fellow eyeJavad N Hajari, Søren S Bjerrum, Ulrik Christensen, et al.
BMC Ophthalmology|October 31, 2023
Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safetyNiklas Cyril Hansen, Anders Hvid-Hansen, Flemming Møller, et al.
Expert Review of Cardiovascular Therapy|August 16, 2022
A review of risk factors for retinal vein occlusionsMarie Ørskov, Henrik Vorum, Torben Bjerregaard Larsen, et al.
Journal of Personalized Medicine|February 23, 2024
Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical TrialNiklas Cyril Hansen, Anders Hvid-Hansen, Flemming Møller, et al.
Journal of Personalized Medicine|December 24, 2025
Correction: Hansen et al. Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial. <i>J. Pers. Med.</i> 2024, <i>14</i>, 175Niklas Cyril Hansen, Anders Hvid-Hansen, Flemming Møller, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 1, 2014
Altered aquaporin expression in glaucoma eyesThuy Linh Tran, Toke Bek, Morten la Cour, et al.
Acta Ophthalmologica|January 19, 2024
Individualised screening for diabetic retinopathy with proliferative retinopathy and macular oedema as separate end pointsToke Bek, Nis Andersen, Jens Andresen, et al.
Experimental Eye Research|July 20, 2023
Porcine models of choroidal neovascularization: A systematic reviewThomas Stax Jakobsen, Bjørn K Fabian-Jessing, Silja Hansen, et al.
Pageof 23

Showing results (161-170 of 225) with videos related to

Sort By:
Pageof 23
Diabetes Care|November 28, 2002
Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathySøren T Knudsen, Toke Bek, Per L Poulsen, et al.
American Journal of Hypertension|April 10, 2002
Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetesSøren Tang Knudsen, Per Løgstrup Poulsen, Klavs Würgler Hansen, et al.
Retina (Philadelphia, Pa.)|July 1, 2014
A nationwide study on the incidence of rhegmatogenous retinal detachment in Denmark, with emphasis on the risk of the fellow eyeJavad N Hajari, Søren S Bjerrum, Ulrik Christensen, et al.
BMC Ophthalmology|October 31, 2023
Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safetyNiklas Cyril Hansen, Anders Hvid-Hansen, Flemming Møller, et al.
Expert Review of Cardiovascular Therapy|August 16, 2022
A review of risk factors for retinal vein occlusionsMarie Ørskov, Henrik Vorum, Torben Bjerregaard Larsen, et al.
Journal of Personalized Medicine|February 23, 2024
Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical TrialNiklas Cyril Hansen, Anders Hvid-Hansen, Flemming Møller, et al.
Journal of Personalized Medicine|December 24, 2025
Correction: Hansen et al. Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial. <i>J. Pers. Med.</i> 2024, <i>14</i>, 175Niklas Cyril Hansen, Anders Hvid-Hansen, Flemming Møller, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 1, 2014
Altered aquaporin expression in glaucoma eyesThuy Linh Tran, Toke Bek, Morten la Cour, et al.
Acta Ophthalmologica|January 19, 2024
Individualised screening for diabetic retinopathy with proliferative retinopathy and macular oedema as separate end pointsToke Bek, Nis Andersen, Jens Andresen, et al.
Experimental Eye Research|July 20, 2023
Porcine models of choroidal neovascularization: A systematic reviewThomas Stax Jakobsen, Bjørn K Fabian-Jessing, Silja Hansen, et al.
Pageof 23